Gut Microbiota Influence on Obesity and Metabolic Health

The gut microbiota exerts a pivotal role in energy balance, fat storage and metabolic health. A complex community of bacteria, archaea, viruses and fungi in the gastrointestinal tract interacts with host physiology via nutrient metabolism, immune modulation and neuroendocrine signalling. Alterations in microbial composition—often termed dysbiosis—are associated with obesity and cardiometabolic disorders. Mechanisms include reduced diversity, depletion of short-chain fatty acid producers, increased endotoxin-producing taxa and modified bile acid profiles. These changes can influence intestinal barrier integrity, systemic low-grade inflammation and insulin sensitivity. Integration of metagenomic, metabolomic and clinical data has refined our understanding of how microbial functions contribute to adiposity, glycaemic control and lipid metabolism, pointing to potential microbiome-targeted interventions for weight management and metabolic disease.

Research from Nature Portfolio

Recent studies have applied large-scale sequencing and machine-learning classifiers to distinguish obese individuals with and without metabolic abnormalities from healthy controls. Shared bacterial genera—including Bacteroides, Parabacteroides, Blautia, Alistipes, Romboutsia and Roseburia—emerged as consistent markers of obesity, while specific taxa correlated with clinical parameters such as lipid profiles, blood pressure and uric acid. Although classifier performance varied across subgroups, these findings underscore the potential of microbial signatures to predict metabolic risk and inform personalised interventions aimed at improving weight and cardiometabolic health.

Gut Microbiota Influence on Obesity and Metabolic Health publication trend

The graph below shows the total number of articles in gut microbiota influence on obesity and metabolic health across all publications each year (not limited to Nature Index journals).

Technical terms

Gut microbiota: The community of microorganisms residing in the gastrointestinal tract and their collective genetic material.

Dysbiosis: A disruption of the normal microbial composition linked to disease states.

Short-chain fatty acids (SCFAs): Metabolites produced by bacterial fermentation of dietary fibre, critical for gut health and energy metabolism.

Metagenomics: The direct sequencing of genetic material from environmental samples to profile microbial communities and functions.

References

1. The Microbiota and Evolution of Obesity. Endocrine Reviews (2024).
2. Meta-analysis reveals obesity associated gut microbial alteration patterns and reproducible contributors of functional shift. Gut Microbes (2024).
3. Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities. Scientific Reports (2019).